My IDSA Contact Us
IDSA NewsPrint-Friendly Newsletter
Forward to a Friend
Search Back Issues
 
Education & Training Resources Practice Guidelines Journals & Publications Policy & Advocacy Meetings About IDSA
February 2012
Patient Care and Science
ACIP Recommends Tdap for All Adults, Including Those 65 and Older

Earlier this month, the federal Advisory Committee on Immunization Practices (ACIP) recommended the Tdap (tetanus-diphtheria-acellular pertussis) vaccine for all adults, including those aged 65 and older. Previously, the vaccine was recommended for those 19 through 64 years old and for adults 65 and older in close contact with young infants. The new guidance calls for all adults 19 and older who have not received the Tdap vaccine already to be given a single dose, according to IDSA’s ACIP liaison, Kathleen M. Neuzil, MD, MPH, FIDSA.  

The committee also heard updates on the current influenza season, which is fairly mild at present, although there is increased activity in certain areas. The new 13-valent pneumococcal conjugate vaccine (PCV13), recently approved for use in adults, was also discussed, but no recommendations were made.

ACIP recommendations become official once approved by the CDC and published in MMWR.
How useful is this article?

< Previous Article | Next Article >

Post a comment

Your name:

Your comment:


Patient Care and Science
CDC Guidance for Influenza Antivirals Remains Unchanged
Medicare Website Reports Hospital CLABSI Rates
ACIP Recommends Tdap for All Adults, Including Those 65 and Older
Drug Approvals, Recalls, Adverse Events Update
Clinical Practice Management
Medicare Physician Payment Cuts Delayed for 10 Months
Global ID
Interview Series: CDC’s Role in Global HIV and TB
Experts Highlight Role of Prevention Interventions in Global AIDS Fight
PEPFAR Takes Hit in Obama’s FY2013 Budget
Policy and Advocacy
Obama’s FY2013 Budget Mixed Bag for ID, HIV/AIDS
HHS Advisory Group Recommends Voluntary Measures to Boost HCW Influenza Vaccination
Your Colleagues
Check Out “My IDSA” for Latest Member News
Education & Resources
CDC Lyme Disease Webinar: CME Credit Available
Adolescent Vaccination Education Materials Available
Top Stories
From the President:
How Is Antimicrobial Resistance Affecting Your Patients?
IDSA Urges Congress, FDA to Boost Antibiotic R&D
IDWeek 2012 Now Accepting Abstract Submissions
IDSA Journal Club

IDSA | 1300 Wilson Blvd., Suite 300 | Arlington, VA 22209 | Phone: (703) 299-0200
To ensure delivery, please add 'info@idsociety.org' to your email address book or Safe Sender List.
If you are still having problems receiving our communications,
see our white-listing page for more details.